News
December 14, 2023
In holding the RUPSLB, Phapros obtains a new captain.
Phapros held an Extraordinary General Meeting of Shareholders (RUPSLB) with the agenda of changing the company's management....
See MoreNovember 27, 2023
Supporting the Implementation of TKDN in the Pharmaceutical Industry, Observer: Cross-Sector Collaboration Is the Key
The implementation of the Domestic Component Level (TKDN) policy in various industries in the country is a necessity....
See MoreNovember 22, 2023
Supporting the "BadminKORPRI" Tournament, Phapros Holds Free Vitamin C Injections
Phapros participated in the BadminKORPRI Tournament organized by the Corps of Indonesian Civil Servants (KORPRI) at the Youth and Sports Ministry Building in Indonesia...
See MoreNovember 17, 2023
Sharia-Compliant Issuers Grow by 82 Percent, Observer: Pharmaceutical Stock Prospects Are Very Attractive
According to data from the Indonesia Stock Exchange, the number of Sharia investors has risen by five percent to 123,359, compared to the previous figure of only 5,457 individuals....
See MoreOctober 31, 2023
The pharmaceutical sector is slowing down nationally, Phapros prepares a strategy to continue growing throughout 2023.
The national pharmaceutical market has not fully recovered in the post-Covid-19 pandemic era....
See MoreOctober 18, 2023
Developing Sustainable Innovations, Phapros Collaborates with Cross-Sectoral Strategic Partners
PT Phapros Tbk, which is part of the State-Owned Pharmaceutical Holding, is committed to making innovation the key to the company's progress....
See More